{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-142745","form_type":"8-K","ticker":"AGIO","cik":"0001439222","company_name":"AGIOS PHARMACEUTICALS, INC.","filed_at":"2025-06-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.306534+00:00","generated_at":"2026-05-19T02:43:07.275988+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Agios shareholders elect two directors, approve 2.5M share plan increase and say-on-pay","bullets":["Class III directors Jacqualyn A. Fouse and David Scadden elected with 45.96M and 46.20M votes for, respectively.","Non-binding say-on-pay approved: 46.84M for, 3.02M against, 16,430 abstain.","2023 Stock Incentive Plan amendment approved: 31.68M for, 18.20M against (36.5% opposition), adding 2.5M authorized shares.","Ratification of PricewaterhouseCoopers as auditor: 51.20M for, 136,734 against, 22,781 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-142745","json":"https://secwatch.observer/filing/0001193125-25-142745.json","markdown":"https://secwatch.observer/filing/0001193125-25-142745.md","text":"https://secwatch.observer/filing/0001193125-25-142745.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1439222/000119312525142745/0001193125-25-142745-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1439222/000119312525142745/d943981d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T02:43:07.275988+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}